| Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted … AS Caudle, WT Yang, S Krishnamurthy, EA Mittendorf, DM Black, ... Journal of Clinical Oncology 34 (10), 1072, 2016 | 760 | 2016 |
| Use of historical control data for assessing treatment effects in clinical trials K Viele, S Berry, B Neuenschwander, B Amzal, F Chen, N Enas, B Hobbs, ... Pharmaceutical statistics 13 (1), 41-54, 2014 | 420 | 2014 |
| Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials BP Hobbs, BP Carlin, SJ Mandrekar, DJ Sargent Biometrics 67 (3), 1047-1056, 2011 | 323 | 2011 |
| Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials WSME Theelen, D Chen, V Verma, BP Hobbs, HMU Peulen, JGJV Aerts, ... The Lancet Respiratory Medicine 9 (5), 467-475, 2021 | 295 | 2021 |
| Time to initial cancer treatment in the United States and association with survival over time: an observational study AA Khorana, K Tullio, P Elson, NA Pennell, SR Grobmyer, MF Kalady, ... PloS one 14 (3), e0213209, 2019 | 240 | 2019 |
| Commensurate priors for incorporating historical information in clinical trials using general and generalized linear models BP Hobbs, DJ Sargent, BP Carlin Bayesian Analysis (Online) 7 (3), 639, 2012 | 193 | 2012 |
| Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer SH Lin, BP Hobbs, V Verma, RS Tidwell, GL Smith, X Lei, EM Corsini, ... Journal of Clinical Oncology 38 (14), 1569, 2020 | 186 | 2020 |
| Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial AS Caudle, WT Yang, EA Mittendorf, DM Black, R Hwang, B Hobbs, ... JAMA surgery 150 (2), 137-143, 2015 | 172 | 2015 |
| A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy HM Kuerer, GM Rauch, S Krishnamurthy, BE Adrada, AS Caudle, ... Annals of surgery 267 (5), 946, 2018 | 170 | 2018 |
| Development of an immune-pathology informed radiomics model for non-small cell lung cancer C Tang, B Hobbs, A Amer, X Li, C Behrens, JR Canales, EP Cuentas, ... Scientific reports 8 (1), 1922, 2018 | 139 | 2018 |
| Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy Y Shiraishi, P Fang, C Xu, J Song, S Krishnan, EJ Koay, RJ Mehran, ... Radiotherapy and Oncology 128 (1), 154-160, 2018 | 121 | 2018 |
| Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis CH Tan, B Paul Hobbs, W Wei, V Kundra American Journal of Roentgenology 204 (4), W439-W448, 2015 | 114 | 2015 |
| Adaptive adjustment of the randomization ratio using historical control data BP Hobbs, BP Carlin, DJ Sargent Clinical Trials 10 (3), 430-440, 2013 | 109 | 2013 |
| Determination of skeletal tumor burden on 18F-fluoride PET/CT EM Rohren, EC Etchebehere, JC Araujo, BP Hobbs, NM Swanston, ... Journal of Nuclear Medicine 56 (10), 1507-1512, 2015 | 88 | 2015 |
| Lymphocyte-sparing effect of proton therapy in patients with esophageal cancer treated with definitive chemoradiation P Fang, Y Shiraishi, V Verma, W Jiang, J Song, BP Hobbs, SH Lin International journal of particle therapy 4 (3), 23-32, 2017 | 80 | 2017 |
| Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study MC Ornstein, SK Pal, LS Wood, JM Tomer, BP Hobbs, XS Jia, KD Allman, ... The Lancet Oncology 20 (10), 1386-1394, 2019 | 77 | 2019 |
| A visually apparent and quantifiable CT imaging feature identifies biophysical subtypes of pancreatic ductal adenocarcinoma EJ Koay, Y Lee, V Cristini, JS Lowengrub, Y Kang, FAS Lucas, BP Hobbs, ... Clinical Cancer Research 24 (23), 5883-5894, 2018 | 77 | 2018 |
| Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison ASR Mohamed, BP Hobbs, KA Hutcheson, MS Murri, N Garg, J Song, ... Radiotherapy and Oncology 124 (2), 232-239, 2017 | 76 | 2017 |
| Bayesian basket trial design with exchangeability monitoring BP Hobbs, R Landin Statistics in medicine 37 (25), 3557-3572, 2018 | 75 | 2018 |
| Practical Bayesian design and analysis for drug and device clinical trials BP Hobbs, BP Carlin Journal of Biopharmaceutical Statistics 18 (1), 54-80, 2007 | 74 | 2007 |
Daniel SargentMayo ClinicGeverifieerd e-mailadres voor mayo.edu
